Neuracin Topical Gel

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Neuracin Topical Gel
Generic name: NEURACIN TOPICAL ANALGESIC GEL
Manufacturer: SOLA Pharmaceuticals
Product type: HUMAN OTC DRUG
SPL set ID: c3166926-30c2-2128-e053-2a95a90a0bf2
SPL ID: 45728450-eb12-7314-e063-6394a90ae6d1
Version: 9
Effective date: 2025-12-08
Source export date: 2026-09-28
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:26:29

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Neuracin Topical Gel	openfda.brand_name
generic name		NEURACIN TOPICAL ANALGESIC GEL	openfda.generic_name
manufacturer name		SOLA Pharmaceuticals	openfda.manufacturer_name
ndc	package	70512-104-60	openfda.package_ndc
ndc	product	70512-104	openfda.product_ndc
ndc11	package	70512010460	derived:openfda.package_ndc
rxcui		1116730	openfda.rxcui
spl id		45728450-eb12-7314-e063-6394a90ae6d1	id
spl set id		c3166926-30c2-2128-e053-2a95a90a0bf2	set_id
unii		L7T10EIP3A	openfda.unii
unii		5TJD82A1ET	openfda.unii
unii		LAV5U5022Y	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For External use only When using this product avoid contact with eyes and mucous membranes do no apply to wounds or damaged skin do not bandage tightly or use with a heating pad use only as directed Stop use and ask a doctor if condition worsens; symptoms last more than 7 days or clear up and occur again within a few days

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.